T. Shaw3, L., Hariprasad, I., V. Messner, L., A. Bansal, C., A. Schechet, S. and Pérez, J. 2022. Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature. BOHR International Journal of Current Research in Optometry and Ophthalmology. 1, 1 (Oct. 2022), 74–79. DOI:https://doi.org/10.54646/bijcroo.2022.19.